These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15189034)

  • 1. Progesterone receptor ligand binding pocket flexibility: crystal structures of the norethindrone and mometasone furoate complexes.
    Madauss KP; Deng SJ; Austin RJ; Lambert MH; McLay I; Pritchard J; Short SA; Stewart EL; Uings IJ; Williams SP
    J Med Chem; 2004 Jun; 47(13):3381-7. PubMed ID: 15189034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced-fit docking of mometasone furoate and further evidence for glucocorticoid receptor 17alpha pocket flexibility.
    Wang H; Aslanian R; Madison VS
    J Mol Graph Model; 2008 Nov; 27(4):512-21. PubMed ID: 18986818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomic structure of progesterone complexed with its receptor.
    Williams SP; Sigler PB
    Nature; 1998 May; 393(6683):392-6. PubMed ID: 9620806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the binding determinants of the glutamate agonist with the glutamate receptor ligand binding domain.
    Speranskiy K; Kurnikova M
    Biochemistry; 2005 Aug; 44(34):11508-17. PubMed ID: 16114887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain.
    Biggadike K; Bledsoe RK; Hassell AM; Kirk BE; McLay IM; Shewchuk LM; Stewart EL
    J Med Chem; 2008 Jun; 51(12):3349-52. PubMed ID: 18522385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure analysis and in silico pKa calculations suggest strong pKa shifts of ligands as driving force for high-affinity binding to TGT.
    Ritschel T; Hoertner S; Heine A; Diederich F; Klebe G
    Chembiochem; 2009 Mar; 10(4):716-27. PubMed ID: 19199329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activity and ligand binding mode to the progesterone receptor of A-homo analogues of progesterone.
    Alvarez LD; Dansey MV; Martí MA; Bertucci PY; Di Chenna PH; Pecci A; Burton G
    Bioorg Med Chem; 2011 Mar; 19(5):1683-91. PubMed ID: 21315613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of the interaction specificity between the human glucocorticoid receptor and its endogenous steroid ligand cortisol.
    von Langen J; Fritzemeier KH; Diekmann S; Hillisch A
    Chembiochem; 2005 Jun; 6(6):1110-8. PubMed ID: 15883974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Met909 plays a key role in the activation of the progesterone receptor and also in the high potency of 13-ethyl progestins.
    Petit-Topin I; Turque N; Fagart J; Fay M; Ulmann A; Gainer E; Rafestin-Oblin ME
    Mol Pharmacol; 2009 Jun; 75(6):1317-24. PubMed ID: 19289570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
    Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
    Celik L; Lund JD; Schiøtt B
    Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking and three-dimensional quantitative structure-activity relationship (3D QSAR) analyses of nonsteroidal progesterone receptor ligands.
    Söderholm AA; Lehtovuori PT; Nyrönen TH
    J Med Chem; 2006 Jul; 49(14):4261-8. PubMed ID: 16821785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretation of scoring functions using 3D molecular fields. Mapping the diacyl-hydrazine-binding pocket of an insect ecdysone receptor.
    Bordas B; Belai I; Lopata A; Szanto Z
    J Chem Inf Model; 2007; 47(1):176-85. PubMed ID: 17238263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
    Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
    J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
    Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
    J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonists.
    Thompson SK; Washburn DG; Frazee JS; Madauss KP; Hoang TH; Lapinski L; Grygielko ET; Glace LE; Trizna W; Williams SP; Duraiswami C; Bray JD; Laping NJ
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4777-80. PubMed ID: 19595590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.
    Zeng J; Li W; Zhao Y; Liu G; Tang Y; Jiang H
    J Phys Chem B; 2008 Mar; 112(9):2719-26. PubMed ID: 18266357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational flexibility in the flap domains of ligand-free HIV protease.
    Heaslet H; Rosenfeld R; Giffin M; Lin YC; Tam K; Torbett BE; Elder JH; McRee DE; Stout CD
    Acta Crystallogr D Biol Crystallogr; 2007 Aug; 63(Pt 8):866-75. PubMed ID: 17642513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs: structural basis for vitamin D receptor antagonism and partial agonism.
    Nakabayashi M; Yamada S; Yoshimoto N; Tanaka T; Igarashi M; Ikura T; Ito N; Makishima M; Tokiwa H; DeLuca HF; Shimizu M
    J Med Chem; 2008 Sep; 51(17):5320-9. PubMed ID: 18710208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.